共 562 条
- [1] Barbati F(2020)Epidemiology of respiratory syncytial virus-related hospitalization over a 5-year period in Italy: evaluation of seasonality and age distribution before vaccine introduction Vaccines (Basel) 8 15-2064
- [2] Moriondo M(2022)Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis Lancet 399 2047-16
- [3] Pisano L(2021)Current state of respiratory syncytial virus disease and management Infect Dis Ther 10 5-520
- [4] Li Y(2020)Update on current views and advances on RSV infection (Review) Int J Mol Med 46 509-2021
- [5] Wang X(2022)Respiratory syncytial virus-associated hospitalisation in children aged ≤ 5 years: a scoping review of literature from 2009 to 2021 ERJ Open Res. 8 00593-801
- [6] Blau DM(2023)Use of respiratory syncytial virus vaccines in older adults: recommendations of the advisory committee on immunization practices—United States, 2023 MMWR Morb Mortal Wkly Rep 72 793-53
- [7] Chatterjee A(2022)Development of mRNA vaccines against respiratory syncytial virus (RSV) Cytokine Growth Factor Rev 68 37-634
- [8] Mavunda K(2023)FDA approves maternal RSV vaccine JAMA 86 628-846
- [9] Krilov LR(2019)Six-monthly palivizumab prophylaxis effectively reduced RSV-associated hospitalization rates of preterm infants in a subtropical area: a population-based cohort study Pediatr Res 11 839-778
- [10] Mammas IN(2023)ACIP update: RSV prevention and updated recommendations on other vaccines Pediatrics 37 768-R462